HDAC9 and hepatocellular carcinoma: Our data revealed that HDAC inhibition and/or RT increased human NKG2D ligands (MICA/B) and murine NKG2D ligands (RAE1, H60) and decreased clonogenic survivals especially when HCC cells were co-cultured with NK cells.